Northeastern University, Translational Biophotonics Cluster, Boston, Massachusetts, United States.
Northeastern University, Department of Physics, Boston, Massachusetts, United States.
J Biomed Opt. 2020 Apr;25(6):1-13. doi: 10.1117/1.JBO.25.6.063811.
Commercial lasers, lamps, and light-emitting diode (LED) light sources have stimulated the clinical translation of photodynamic therapy (PDT). Yet, the continued exploration of new photosensitizers (PSs) for PDT often requires separate activation wavelengths for each agent being investigated. Customized light sources for such research frequently come at significant financial or technical cost, especially when compounded over many agents and wavelengths.
LEDs offer potential as a cost-effective tool for new PS and multi-PS photodynamic research. A low-cost-per-wavelength tool leveraging high-power LEDs to facilitate efficient and versatile research is needed to further accelerate research in the field.
We developed and validated a high-power LED array system for benchtop PDT with a modular design for efficient switching between wavelengths that overcome many challenges in light source design. We describe the assembly of a low-cost LED module plus the supporting infrastructure, software, and protocols to streamline typical in vitro PDT experimentation.
The LED array system is stable at intensities in excess of 100 mW / cm2 with 2.3% variation across the illumination field, competitive with other custom and commercial devices. To demonstrate efficacy and versatility, a primary ovarian cancer cell line was treated with two widely used PSs, aminolevulinic acid and verteporfin, using the LED modules at a clinically relevant 50 J / cm2 light dose that induced over 90% cell death for each treatment.
Our work provides the community with a tool for new PS and multi-PS benchtop photodynamic research that, unlike most commercial light sources, affords the user a low barrier to entry and low-cost-per-wavelength with the goal of illuminating new insights at the forefront of PDT.
商业激光器、灯和发光二极管 (LED) 光源刺激了光动力疗法 (PDT) 的临床转化。然而,新光敏剂 (PS) 的持续探索通常需要为每个正在研究的药物分别激活波长。此类研究的定制光源通常需要付出巨大的经济或技术成本,尤其是当涉及许多药物和波长时。
LED 有可能成为一种具有成本效益的新 PS 和多 PS 光动力研究工具。需要一种具有低成本每波长特性的工具,利用高功率 LED 来实现高效和多功能的研究,以进一步加速该领域的研究。
我们开发并验证了一种用于台式 PDT 的高功率 LED 阵列系统,该系统具有模块化设计,可在波长之间高效切换,克服了光源设计中的许多挑战。我们描述了低成本 LED 模块的组装以及支持基础设施、软件和协议,以简化典型的体外 PDT 实验。
LED 阵列系统在超过 100 mW/cm2 的强度下稳定,在照明场中具有 2.3%的变化,与其他定制和商业设备具有竞争力。为了证明功效和多功能性,使用 LED 模块以临床相关的 50 J/cm2 光剂量对一种原发性卵巢癌细胞系进行了两种广泛使用的 PS(氨基酮戊酸和维替泊芬)的处理,每种处理都诱导超过 90%的细胞死亡。
我们的工作为社区提供了一种用于新 PS 和多 PS 台式光动力研究的工具,与大多数商业光源不同,该工具为用户提供了低进入门槛和低成本每波长的优势,旨在为 PDT 的前沿提供新的见解。